Clinical trials in vision research sponsored by the National Eye Institute (NEI) a division of the National Institutes of Health (NIH) have led to new medications, supplements and methods for disease detection that have saved or improved the eyesight of millions of people. We have been at the forefront of many of these including AREDS, AREDS 2, SCORE, SCORE 2, DRCRnet trials, Pedig pediatric trials, CAPT, and CATT. Many of these trials reveal important data for safe and effective treatments for eye diseases and vision loss.
While CERU serves as the primary clinical research team for DOVS, we actively collaborate studies that can affect the eye in any way. CERU is often involved in clinical trials initiated by departments within the UW–Madison School of Medicine and Public Health and extend all across campus, including UW Hospital and Carbone Cancer Center.
CERU provides top imaging and diagnostics technology for most ophthalmology-related trial needs. CERU has decades of experience coordinating trials for Phase I, II, III, and IV studies, anywhere from small, local investigator-initiated trials to large nationwide studies.
Our staff are certified clinical research coordinators with the Association of Clinical Research Professionals. Our areas of expertise include, but are not limited to; technical assessments and direct patient care, patient education and advocacy, data collection and management, and regulatory compliance.
The CERU is a leading resource for investigator-initiated clinical research projects, clinical trials, education of future generations of clinical researchers, and serves as the liaison for interdisciplinary collaborations with other departments at the University of Wisconsin-Madison.
— Dr. Mihai Mititelu, Associate Professor, Medical Director of Clinical Eye Research Unit
Clinical Eye Research Unit Team
Mihai Mititelu, MD, MPH
Associate Professor, Clinical Eye Research Unit Medical Director
Active Clinical Trials
For more information regarding our active clinical trials, please follow the link below.
Indisputably, our most important role is to guide patients through the treatment of their difficult eye condition, offering them not only the most current medical techniques and treatments, but also compassionate and knowledgeable care committed to protecting their safety.
— Jennie Perry-Raymond, Clinical Trials Administrator
Archived list of past clinical trials over the last 50 years as a leader in ophthalmic research is forthcoming.
CONTACT US.